{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:18:51Z","timestamp":1788823131080,"version":"build-2803163510"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In an effort to manage health care costs and avoid improper medication use, prior authorizations (PAs) have become a standard stipulation required by payers in the determination of medication coverage. For gastroenterologists managing patients, especially those with inflammatory bowel disease (IBD), the PA process is time-consuming and further complicated by 2 additional factors: step therapy requirements and failure of payers to recognize updated IBD treatment pathways. These factors often lead to PA denials and cause treatment delays, which in turn can lead to disease progression, ongoing patient suffering, and ultimately an increase in both direct and indirect total costs. In this manuscript, the PA process, PA models, tips and available resources to navigate the PA process, and future advocacy efforts are discussed with the intent to help gastroenterology practices optimize PA outcomes and improve the care provided to patients with IBD and other gastrointestinal disorders.<\/jats:p>","DOI":"10.1093\/ibd\/izz013","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T19:09:33Z","timestamp":1549652973000},"page":"1621-1628","source":"Crossref","is-referenced-by-count":24,"title":["Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7023-9506","authenticated-orcid":false,"given":"Shubha","family":"Bhat","sequence":"first","affiliation":[{"name":"Center for Digestive Disorders, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni","family":"Zahorian","sequence":"additional","affiliation":[{"name":"Center for Digestive Disorders, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"Robert","sequence":"additional","affiliation":[{"name":"Center for Digestive Disorders, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis A","family":"Farraye","sequence":"additional","affiliation":[{"name":"Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"2019091808543274000_CIT0001","unstructured":"Crohn\u2019s and Colitis Foundation. Step therapy. http:\/\/www.crohnscolitisfoundation.org\/ (accessed November 15, 2018)."},{"key":"2019091808543274000_CIT0002","author":"American Gastroenterological Association"},{"key":"2019091808543274000_CIT0003","author":"American Gastroenterological Association"},{"key":"2019091808543274000_CIT0004","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/MIB.0000000000001153","article-title":"Variations in health insurance policies regarding biologic therapy use in inflammatory bowel disease","volume":"23","author":"Yadav","year":"2017","journal-title":"Inflamm Bowel Dis."},{"key":"2019091808543274000_CIT0005","author":"Rubin"},{"key":"2019091808543274000_CIT0006","author":"RN Sights"},{"key":"2019091808543274000_CIT0007","author":"MDLinx"},{"key":"2019091808543274000_CIT0008","author":"Crohn\u2019s and Colitis Foundation"},{"key":"2019091808543274000_CIT0009","unstructured":"Academy of Managed Care Pharmacy. Electronic prior authorization (ePA). http:\/\/www.amcp.org\/ePA\/ (accessed November 15, 2018)."},{"key":"2019091808543274000_CIT0010"},{"key":"2019091808543274000_CIT0011","author":"The Congressional Research Service of the Library of Congress"},{"key":"2019091808543274000_CIT0012","unstructured":"Crohn\u2019s and Colitis Foundation. Co-Sponsor HR 2077: Restoring the Patient\u2019s Voice Act. http:\/\/www.crohnscolitisfoundation.org\/assets\/pdfs\/advocacy\/hr-2099-restoring-the.pdf (accessed November 15, 2018)."},{"key":"2019091808543274000_CIT0013","author":"American Medical Association"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/10\/1621\/30030462\/izz013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T08:56:43Z","timestamp":1568797003000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/10\/1621\/5310379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":13,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,2,8]]},"published-print":{"date-parts":[[2019,9,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izz013","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10]]},"published":{"date-parts":[[2019,2,8]]}}}